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Abstract Rhodopsin phosphorylation was investigated using 
synthetic C-terminal peptides from rhodopsin. The peptides were 
phosphorylated by expressed rhodopsin kinase (RK) in the 
presence of a photolyzed truncated rhodopsin at the C-terminus. 
No peptide phosphorylation was detected under dark or in 
conditions in which RK was inactive. However, the phosphoryla-
tion rate was significantly higher in the following three peptides: 
(345M Rho, 330DDEASTTVSKTETSQMAPA; 347S Rho, 
330DDEASTTVSKTETSQVASA; and 347L Rho: 
330DDEASTTVSKTETSQVALA) taken from missense muta-
tions of rhodopsin found in patients with autosomal retinitis 
pigmentosa (ADRP) as compared with that from wild-type 
rhodopsin (330DDEASTTVSKTETSQVAPA). Distribution of 
the phosphorylation showed a similar ratio among three serines 
(334, 338 and 343) in 347L Rho mutation to wild type. However, 
345M Rho and 347S Rho peptides showed higher phosphoryla-
tion at Ser334. The data obtained suggests that an abnormally 
high rate of phosphorylation in missense mutations around the 
rhodopsin C-terminus may change the position of phosphoryla-
tion and inactivation process of the visual transduction. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Retinitis pigmentosa (RP) is a group of an inherited disease 
of progressive retina degeneration with characteristic features 
including nyctalopia, ring scotoma, and bone spicule pigmen-
tation of the retina. A major cause of the autosomal dominant 
form of RP (ADRP) is mutation of the rhodopsin gene [1,2]. 
More than 60 different rhodopsin mutations distributed all 
regions of rhodopsin, intradiscal, transmembrane, cytoplasmic 
loop and C-terminal domains have been described [2]. 
Rhodopsin is the most abundant membrane-spanning pro-
tein in the rod outer segments. Following absorption of a 
photon, rhodopsin isomerizes into an active photobleaching 
intermediate (metarhodopsin II), which initiates a G-protein 
(Gt) mediated amplifying cascade of reactions to generate 
visually evoked signals in photoreceptor cells [3]. This cascade 
is shut down by phosphorylation of photolyzed rhodopsin by 
rhodopsin kinase (RK) resulting in blockage of further inter-
action of metarhodopsin II with Gt by binding with arrestin 
[3]. In vitro and in vivo studies revealed that light-dependent 
phosphorylation of rhodopsin occurs at one of three serine 
(Ser334, Ser338 and Ser343) and one threonine (Thr336) residues 
at the C-terminal segment [4-8]. Within the C-terminal cyto-
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plasmic domain, the four terminal amino acids, Val345-Ala-
Pro-Ala, are highly conserved in mammals, and Val34° and 
Pro347 are the most common sites of mutations causing 
ADRP [2]. The disease phenotype can be mild or severe. 
Studies by site-directed mutagenesis showed that these mis-
sense mutants possess wild-type biochemical properties in-
cluding gene product synthesis, transport and immunogenic 
properties [9,10]. The molecular pathophysiology of retinal 
degeneration in ADRP with these mutations is still unknown. 
However, the above information led us to speculate that the 
missense mutations in this region may effect rhodopsin phos-
phorylation. 
Here, to test this hypothesis, we studied phosphorylation of 
rhodopsin with missense mutations near the phosphorylation 
sites using a peptide phosphorylation system and found sig-
nificantly increased levels of rhodopsin phosphorylation in 
these missense mutations. 
2. Materials and methods 
2.1. Materials 
A bovine rhodopsin 19-amino-acid C-terminal peptide 
(330DDEASTTVSKTETSQVAPA) and three peptides with missense 
mutations (330DDEASTTVSKTETSQMAPA, 330DDEASTTVSK-
TETSQVASA, and 330DDEASTTVSKTETSQVALA) were pur-
chased from Quality Controlled Biochemicals (MA). The sequences 
were verified by amino-acid composition and Edman sequence analy-
sis. Rhodopsin truncated at Gly329 (D-Rho) was prepared by proteo-
lysis of urea-washed rhodopsin by endoproteinase Asp-N, and re-
combinant RK was expressed in insect cells and purified as 
described previously [11]. All other reagents used were analytical 
grade. 
2.2. Phosphorylation of rhodopsin C-terminal peptides 
Synthetic rhodopsin C-terminal 19-amino-acid peptides (66 aM) 
were phosphorylated in a total of 150 ul of 50 mM BTP (bis-tris-
propane) buffer containing 5 mM MgCl2 in the presence of D-Rho 
(50 |iM), recombinant RK (300 pmole of phosphate transfer/min/kin-
ase activity) and 0.167 mM [32P]ATP (300 cpm/nmol) at 30°C for 30 
min under a 150-W lamp from a distance of 30 cm. The reaction was 
terminated by adding 10% acetic acid. The mixture was passed 
through a DEAE cellulose column (5 X 10 mm) which had been equil-
ibrated with 5% acetic acid. A large excess of ATP bound to the 
column. Phosphorylated and unphosphorylated rhodopsin C-terminal 
peptides unbound to the column were directly injected to a HPLC 
reverse phase column (2.1X250 mm, C18 column, Vydac 218TP52) 
and purified employing a linear gradient of acetonitrile from 0% to 
24% and from 0.08% to 0.1% trifluoroacetic acid during 40 min at a 
flow rate of 0.3 ml/min. Fractions (0.3 ml each) were collected and the 
radioactivities were counted by Cerenkov's method. 
2.3. Determination of the site of phosphorylation 
The phosphorylation sites of rhodopsin C-terminal peptides were 
estimated from the radioactive 32P-elution profiles of their subdiges-
tion by trypsin as described by Ohguro et al. [7]. Briefly, C-terminal 
phosphorylated peptides were each treated with 1 jig of TPCK-trypsin 
(Worthington) at 30°C for 1 h and directly injected to a C18 reverse 
phase HPLC column (2.1 X 250 mm, Vydac218TP52). Peptides phos-
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phorylated at different sites were separated by elution with a linear 
gradient from 0% to 24% acetonitrile and from 0.08% to 0.1% tri-
fiuoroacetic acid for 60 min at a flow rate of 0.3 ml/min. Fractions 
(0.3 ml each) were collected and the radioactivities were counted by 
Cerenkov's method. 
3. Results and discussion 
It was found that authentic peptides corresponding to the 
C-terminal region of rhodopsin can be phosphorylated by RK 
in the presence of photobleaching intermediates of rhodopsin, 
or the truncated form of rhodopsin at the C-terminus [12,13]. 
Akhtar and his colleague [12,14,15] have shown that the ki-
netics and distribution of phosphorylation of the peptide were 
identical with that of native receptors although the rate of 
phosphorylation is relatively low (less than 10%). By utilizing 
this methodology, we have studied phosphorylation of rho-
dopsin with missense mutations at the C-terminus found in 
ADRP in order to elucidate its molecular pathophysiology. 
For the selection of the authentic peptide, the following pre-
vious observations were taken into account: (1) bovine rho-
dopsin is the best studied species; (2) serine residues at 334, 
338 or 343 are the initial sites of phosphorylation in vitro and 
in vivo studies [4-8]; (3) 9-12 amino acids from the C-termi-
nal region were preferable substrates for RK, but the stoichi-
ometry and the distribution were changeable by the position 
(one residue on the amino side and five on the acyl side were 
at least required for suitable phosphorylation) [12,14,15]; (4) a 
C-terminal 19-amino-acid peptide obtained by endoproteinase 
Asp N was extensively characterized [4-8,11,13]. From these 
observation, we designed a reconstituted experiment using a 
C-terminal 19-amino-acid peptide from bovine rhodopsin, 
330DDEASTTVSKTETSQVAPA, and a truncated form of 
rhodopsin at Gly329 (D-Rho) eliminated the 19 amino acids, 
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Fig. 1. Phosphorylation of rhodopsin C-terminal peptide catalyzed 
by rhodopsin kinase. Phosphorylation of rhodopsin C-terminal pep-
tide, 330DDEASTTVSKTETSQVAPA, was catalyzed by expressed 
RK in the presence of photolyzed D-Rho and [32P]ATP as described 
in Section 2. As a control, experiments were performed under sev-
eral conditions in the dark, without peptide, or conditions where en-
dogenous and exogenous RK were inactivated by adding acid. Phos-
phorylated and unphosphorylated peptides were purified by HPLC 
column and their radioactivities were counted. Experiments were 
performed in duplicate. 
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Fig. 2. Phosphorylation of C-terminal peptides of rhodopsin with 
missense mutations in ADRP by RK. Three peptides (345M Rho, 
330DDEASTTVSKTETSQMAPA; 347S Rho, 330DDEASTTVSK-
TETSQVASA; and 347L Rho, 330DDEASTTVSKTETSQVALA) 
from missense mutations observed in patients with ADRP were 
phosphorylated by RK in the presence of D-Rho under dark or 
light conditions. Phosphorylated and unphosphorylated peptides 
were purified by HPLC column and their radioactivities were 
counted. Experiments were performed in duplicate. 
and expressed RK. As shown in Fig. 1, the peptide was re-
markably phosphorylated by the expressed RK under white 
light illumination in the presence of D-Rho, while no phos-
phorylation was detected in conditions without the peptide or 
D-Rho, or under dark conditions. The peptide was also un-
phosphorylated when endogenous and exogenous RK were 
inactivated by adding acid to the mixture. Thus, phosphoryl-
ation of the rhodopsin peptide occurred in a light and RK 
dependent manner like native forms, and is suitable for study 
further using mutant peptides. 
Three peptides (345M Rho, 330DDEASTTVSKTETSQ-
MAPA; 347S Rho, 330DDEASTTVSKTETSQVASA; and 
347L Rho, 330DDEASTTVSKTETSQVALA) from missense 
mutations frequently observed in patients with ADRP [2] were 
synthesized and examined for their phosphorylation proper-
ties. As shown in Fig. 2, all peptides were phosphorylated by 
RK in a light-dependent manner, but the rates of phosphoryl-
ation of these mutant peptides were twice to three times high-
er than that in the wild-type peptide. The distribution of 
mono-phosphorylation at Ser334, Ser338 or Ser343 in 347L 
Rho peptide was almost identical to that in the normal pep-
tide, while 347S Rho and 345M Rho peptides showed signifi-
cantly higher rates of phosphorylation at Ser334 site (Fig. 3). 
In our previous study using mice, we found different kin-
etics of phosphorylation and dephosphorylation among 
Ser334, Ser338 and Ser343 sites [8], and suggested that rhodopsin 
phosphorylation at specific sites may be involved in the differ-
ent inactivation processes, such as quenching and adaptation. 
In vitro, the distribution of rhodopsin phosphorylation 
among the three serines were not affected by different bleach-
ing states of rhodopsin (meta I, meta II, meta III), removal of 
palmitiol groups at Cys322Cys323 that anchor the C-terminal 
domain to disc membrane, nor by other factors (arrestin, ret-
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Fig. 3. Distribution of phosphorylation on the C-terminal peptides 
from normal and mutant rhodopsin. Percents of mono-phosphoryl-
ated rhodopsin at different sites, Ser334 (open), Ser338 (dot), or 
Ser343 (stripe) were determined by radioactive 32P-pronles of the 
trypsin digests of the C-terminal peptides as described in Section 2. 
Experiments were performed in duplicate. 
inol dehydrogenase, Gt and recoverin). However, truncation 
of the C-terminal four to nine amino acids of rhodopsin by 
proteolytic enzymes led to different stoichiometry of phos-
phorylation among the three serines, and unique initial phos-
phorylation at Thr336 which has never been found before [11]. 
Taken together with the current data, it was concluded that 
the C-terminal tail of rhodopsin is a key region conducive to 
the kinetics and distribution of phosphorylation. 
The molecular pathophysiology of ADRP with missense 
mutations has not been elucidated yet. Mutagenesis studies 
have hypothesized that prolonged activation of the rod caused 
by constitutive activation of Gt could lead to cell death by 
way of unknown events [16-18]. A prolonged desensitization 
caused by an absence or decrease of rhodopsin phosphoryla-
tion is a critical factor of retinal degeneration as shown by the 
following observations: (1) Absence of rhodopsin phosphoryl-
ation was found in some rhodopsin mutants [19]; (2) Trans-
genic mice carrying rhodopsin C-terminal truncation at Gly329 
[20] or Glu344 [21] showed prolonged responses and retinal 
degeneration. However, in contrast, missense mutations with-
in the rhodopsin C-terminus most frequently found in ADRP 
showed an increase of phosphorylation as described above. 
This process may involve accelerated desensitization produc-
ing a change of status of visual transduction pathways also 
resulting in retinal degeneration. However, our understanding 
of the above process and how it leads to cell death is at 
present speculative and consequently further study is required. 
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